ASTRAZENECA PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge
SEC filing record 1 source field available
Fiscal year end
31 December
ASTRAZENECA PLC has filed 2,050 SEC EDGAR filings since 13 Mar 1995

SEC filing history

Showing 426-450 of 1,000 matching filings.

Per page
25
Current page
18
6-K File 001-11960

ASTRAZENECA PRICES A EUR1.5BN BOND OFFERING

Filing date
24 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA ACQUIRES CINCOR FOR CARDIORENAL ASSET

Filing date
24 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
24 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
24 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA ENTERS AGREEMENT WITH KYM FOR CMG901

Filing date
23 Feb 2023
Reporting date
23 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T

Filing date
23 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FILING OF FORM 20-F WITH SEC

Filing date
22 Feb 2023
Reporting date
22 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORM 6-K

Filing date
21 Feb 2023
Reporting date
21 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
IRANNOTICE File 001-11960

IRANNOTICE

Filing date
21 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ANNUAL FINANCIAL REPORT

Filing date
21 Feb 2023
Reporting date
21 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
13 Feb 2023
Reporting date
13 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
13 Feb 2023
Reporting date
13 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FINAL RESULTS

Filing date
09 Feb 2023
Reporting date
09 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
01 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

UPDATE ON EVUSHELD US EUA

Filing date
26 Jan 2023
Reporting date
26 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-55247

SC 13G/A filing

Filing date
24 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T

SC TO-T

Filing date
23 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ACQUISITION OF NEOGENE THERAPEUTICS COMPLETED

Filing date
17 Jan 2023
Reporting date
17 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

AIRSUPRA (PT027) APPROVED IN US FOR ASTHMA

Filing date
11 Jan 2023
Reporting date
11 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
09 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA ACQUIRE CINCOR FOR CARDIORENAL ASSET

Filing date
09 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .